WS #15210

The dominant market narrative has shifted from geopolitical risk to macroeconomic recalibration. The US PCE inflation report came in cooler than expected (Core 3.0% vs 3.3% forecast), providing a temporary reprieve for equities and dampening the urgency of the bond market's yield spike. However, the 10-Year yield remains structurally elevated near 5.27%, creating a bifurcated market where mega-cap tech (MSFT, NVDA) rallies on AI optimism and earnings, while small-caps and rate-sensitive sectors (real estate, consumer discretionary) struggle under the weight of high borrowing costs. In the energy complex, a distinct divergence is emerging. While geopolitical headlines regarding the Strait of Hormuz and Iranian attacks on tankers persist, physical market data—specifically the resumption of Yanbu exports and a 40mb SPR release—has driven Brent crude down 2.6% to $102.59. This supply-side resolution counters the geopolitical premium, benefiting airlines and refiners while pressuring pure-play energy names. Simultaneously, China's state refiners halting fuel exports signals weakening global demand, adding a deflationary pressure to the oil price decline. Corporate action is concentrated in technology and defense. HPE continues its momentum with a massive $1.2B Vultr order, while Rocket Lab secured its largest commercial launch deal. In biotech, the sector remains volatile with mixed clinical data (Foghorn ending a program vs. Anixa advancing CAR-T). The macro backdrop of cooling inflation supports a 'soft landing' thesis, but the persistent high-yield environment limits broad market participation, favoring quality and cash-generative businesses.